You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九安醫療(002432.SZ)業績快報:2021年度淨利升276.87%至9.13億元
格隆匯 04-12 08:03

格隆匯4月12日丨九安醫療(002432.SZ)披露2021年度業績快報,報吿期內,公司實現營業總收入25.13億元,同比增長25.11%;歸屬於母公司所有者的淨利潤9.13億元,同比增長276.87%;歸屬於母公司所有者的扣除非經常性損益的淨利潤8.32億元,同比增長236.03%。

2021年,公司利用多年在IVD(體外診斷產品)和FDA申請方面積累的經驗優勢,同時發揮iHealth美國子公司的的地緣優勢,於2021年11月5日(美國當地時間)獲得新冠抗原家用自測OTC試劑盒的美國FDAEUA授權,支持當地公共衞生防疫,方便個人及家庭進行快速、及時的篩查。受美國奧密克戎疫情發展的影響,當地對新冠抗原檢測試劑盒產品需求大幅增長。

2021年末,公司總資產39.57億元,比年初增長60.29%;歸屬於母公司的所有者權益28.73億元,比年初增長52.43%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account